» Articles » PMID: 7347560

Cefoxitin Disposition During Peritoneal Dialysis

Overview
Specialty Pharmacology
Date 1981 Feb 1
PMID 7347560
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmacokinetic disposition of 2 g of cefoxitin administered intravenously over 30 min was determined in six patients undergoing continuous ambulatory peritoneal dialysis for chronic renal failure. During the 6-h dialysate dwell time after the drug infusion, the mean apparent volume of distribution for cefoxitin was 0.267 liter/kg (range, 0.201 to 0.325 liter/kg), and the mean elimination t1/2 from plasma was 7.8 h (range, 5.5 to 13.1 h). The peritoneal clearance, averaging 1.51 ml/min (range, 0.58 to 2.35 ml/min), was only 7.4% of the mean plasmas clearance of cefoxitin. Cefoxitin clearance was reduced in patients with renal failure and was not increased by peritoneal dialysis.

Citing Articles

Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review.

Janknegt R, Koks C Pharm Weekbl Sci. 1984; 6(6):229-36.

PMID: 6393041 DOI: 10.1007/BF01954550.


Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis.

Arvidsson A, Alvan G, Tranaeus A, MALMBORG A Eur J Clin Pharmacol. 1985; 28(3):333-7.

PMID: 4007038 DOI: 10.1007/BF00543333.


Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.

Paton T, Cornish W, MANUEL M, Hardy B Clin Pharmacokinet. 1985; 10(5):404-25.

PMID: 3899455 DOI: 10.2165/00003088-198510050-00003.

References
1.
Rubin J, Rogers W, Taylor H, EVERETT E, Prowant B, Fruto L . Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med. 1980; 92(1):7-13. DOI: 10.7326/0003-4819-92-1-7. View

2.
Humbert G, Fillastre J, Leroy A, Godin M, van Winzum C . Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency. Rev Infect Dis. 1979; 1(1):118-26. DOI: 10.1093/clinids/1.1.118. View

3.
Popovich R, Moncrief J, Nolph K, Ghods A, Twardowski Z, Pyle W . Continuous ambulatory peritoneal dialysis. Ann Intern Med. 1978; 88(4):449-56. DOI: 10.7326/0003-4819-88-4-449. View

4.
Garcia M, Dominguez-Gil A, Tabernero J, Bondia Roman A . Pharmacokinetics of cefoxitin in patients undergoing hemodialysis. Int J Clin Pharmacol Biopharm. 1979; 17(8):366-70. View

5.
Trollfors B, Norrby R, Kristianson K, NILSSON N . Effects on renal function of treatment with cefoxitin alone or in combination with furosemide. Scand J Infect Dis Suppl. 1978; (13):73-7. View